ArticleCancer immunology, immunotherapy : CII2024

Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes.

Konstantinos Ntostoglou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.